Answers are grounded in this paper and cite their sources.
Rationale: Takayasu arteritis (TA) is a systemic granulomatous large-vessel vasculitis predominantly involving the aorta and its primary branches. Sarcoidosis is a systemic granulomatous disorder characterized histologically by non-necrotizing epithelioid granulomas, most commonly affecting the lungs. Although the coexistence of TA and sarcoidosis has been documented, bone marrow involvement by sarcoidosis in a patient with concomitant TA has not, to our knowledge, been previously reported. Patient concerns: A 46-year-old woman with a confirmed diagnosis of TA presented with elevated systemic inflammatory markers and diffuse hypermetabolic activity on positron emission tomography (PET). Clinical, radiological, and pathological evaluations were performed. Diagnoses: Bone marrow biopsy revealed multiple non-necrotizing granulomas, supporting bone marrow involvement by sarcoidosis. This overlap of granulomatous conditions was identified in the context of persistent systemic inflammation. Interventions: Mycofenolate Mofetil was replaced by Infliximab therapy. Outcomes: The patient exhibited significant clinical improvement and marked improvement in inflammatory markers with infliximab therapy. Lessons: This case highlights the importance of maintaining a broad differential diagnosis in patients with autoimmune or inflammatory diseases who develop new systemic manifestations. Recognizing rare organ involvement in overlapping granulomatous conditions is critical for accurate diagnosis and management.
No takes yet. Share an insight, caveat, or question.
Fakih et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: